8
Participants
Start Date
November 21, 2017
Primary Completion Date
November 13, 2018
Study Completion Date
November 13, 2018
Ipratropium Bromide
Single dose of 500 mcg Ipratropium nebulizer solution will be administered to all subjects via inhalation route using nebulizer for 10 minutes. Ipratropium bromide is a clear, colorless nebulizer solution available in white plastic ampoules.
Flexible Bronchoscopy/Biopsy
After biopsy samples required for diagnosis have been collected, additional one to two TBCB samples will be taken for this study. 3-5 endobronchial biopsy samples will be taken from up to 5 subjects to compare drug distribution in proximal and distal lung.
GSK Investigational Site, London
Lead Sponsor
University College London Hospitals
OTHER
GlaxoSmithKline
INDUSTRY